Viewing Study NCT02641093


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-01-17 @ 12:53 AM
Study NCT ID: NCT02641093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-29
First Post: 2015-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Sponsor: Trisha Wise-Draper
Organization: